Spaulding Clinical Research said Monday it plans to partner with Aurora Health Care to open a research unit at Aurora Sinai Medical Center. The 18-bed unit will conduct Phase I clinical trials that test the safety of potential drugs. Read the full Milwaukee Journal Sentinel story here.